<DOC>
	<DOC>NCT00670436</DOC>
	<brief_summary>The aim of the study is to assess the safety and efficacy of a Paclitaxel-eluting PTCA-balloon in combination with bare-metal stenting for treatment of chronic total occlusions in native coronary arteries with reference diameters between 2.5 mm and 4.0 mm.</brief_summary>
	<brief_title>The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>chronic total occlusion Thrombolysis in Myocardial Infarction (TIMI) flow 0 or 1 occlusion in native coronary artery indication for percutaneous coronary intervention based on symptoms, prognosis or evidence of ischemia reference diameter 2.5 mm to 4.0 mm saphenous vein graft bifurcation lesion with need to stent main and side branch left main occlusion denovo stenosis (no occlusion) restenosis instent restenosis contraindication for dual antiplatelet therapy with acetylsalicylic acid and clopidogrel for 6 months coronary aneurysm at target lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>